Related Experiment Video
Updated: Aug 15, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Aripiprazole in psychosis associated with Parkinson's disease
Elmer López-Meza1, Angel Ruiz-Chow, Jesus Ramirez-Bermudez
1Clinical Investigation Dept., National Institute of Neurology and Neurosurgery of México. Insurgentes sur 3877, Colonia la fama, Tlalpan, Mexico DF 14269. elmerlopez@hotmail.com
Abstract:
Aripiprazole is an agent for treating schizophrenia. The authors assume that aripiprazole as a dopamine receptor partial agonist may be useful in treating PD patients. Three cases are presented in this study. All patients were evaluated by the same clinician, a neuropsychiatrist well trained in the use of Brief Psychiatric Rating Scale (BPRS) and Clinical Global Impression (CGI). Aripiprazole was effective for reducing psychosis in each case.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Psychosis and Antipsychotic Drugs: Overview
Parkinson Disease l: Introduction
Antipsychotic Drugs: Typical and Atypical Agents
Psychosis: Goals of Pharmacotherapy
Parkinson's Disease: Overview